Skip to main content

Table 2 Comparison of clinical characteristics between PCOS patients (n = 217) and controls (n = 144)

From: The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome

Characteristics

PCOS patients (n = 217)

Controls (n = 144)

Hyperandrogenism and Oligo- or amenorrhea

n = 33 (15.2%)

n = 0 (0.0%)

Hyperandrogenism and Polycystic ovaries

n = 18 (8.3%)

n = 0 (0.0%)

Oligo- or amenorrhea and polycystic ovaries

n = 141 (65%)

n = 0 (0.0%)

Hyperandrogenism, Oligo- or amenorrhea and polycystic ovaries

n = 22 (10.1%)

n = 0 (0.0%)